MTMR9

MTMR9 is a catalytically inactive member of the myotubularin family that functions as a regulatory subunit, partnering with active 3-phosphatases to control phosphoinositide metabolism and downstream cellular processes (PMID:22647598). Through its coiled-coil domain it heterodimerizes with the active phosphatases MTMR6, MTMR7, and MTMR8, and these complexes dictate both catalytic output and substrate preference: the MTMR6/MTMR9 complex strongly prefers PtdIns(3,5)P2 with activity increased over 30-fold and raises cellular PtdIns(5)P, whereas the MTMR8/MTMR9 complex prefers PtdIns(3)P (PMID:12890864, PMID:22647598). Beyond activating its partners, MTMR9 stabilizes them against degradation and enhances their association with phospholipid membranes (PMID:19038970). Functionally, the MTMR6/MTMR9 complex inhibits stress-induced apoptosis while the MTMR8/MTMR9 complex inhibits autophagy (PMID:22647598). MTMR9 localizes to the intermediate compartment and Golgi apparatus, where it recruits MTMR6 and MTMR8, regulates RAB1A localization, maintains Golgi integrity, and supports protein secretion including that of WNT3A (PMID:31704058). In CD4 T cells MTMR9 suppresses Th1 differentiation and limits AKT phosphorylation, consistent with regulation of phosphoinositide signaling (PMID:23630283).

1. 2003 High

   Established that MTMR9 is a binding partner of an active myotubularin and that this physical association modulates enzymatic output, defining MTMR9 as a regulatory rather than catalytic protein.

   Evidence Co-immunoprecipitation with MS identification, domain mapping, and in vitro phosphatase assay in neuroblastoma cells

   PMID:12890864

   Open questions at the time

   • Did not test other active MTMR partners
   • Cellular consequences of the activity increase not addressed
   • Structural basis of CC-mediated binding not resolved
2. 2006 Medium

   Extended the partnership repertoire by showing MTMR9 pairs with MTMR8, supporting a general model in which inactive MTMRs heteromerize with active members.

   Evidence Directed yeast two-hybrid and co-immunoprecipitation of epitope-tagged proteins

   PMID:16787938

   Open questions at the time

   • Functional output of the MTMR8-MTMR9 pair not measured here
   • No endogenous complex confirmation
   • Stoichiometry undefined
3. 2008 High

   Demonstrated that MTMR9 both activates MTMR6's 3-phosphatase activity and stabilizes the partner proteins, linking the complex to cell survival.

   Evidence In vitro phosphatase assays with liposomes, Co-IP, protein stability Western blots, RNAi knockdown with apoptosis readout

   PMID:19038970

   Open questions at the time

   • Mechanism of protein stabilization (degradation pathway) not identified
   • Substrate specificity not yet dissected
4. 2012 High

   Resolved how complex composition determines substrate specificity and cellular function, showing distinct phosphoinositide preferences and divergent control of apoptosis versus autophagy.

   Evidence Reconstituted in vitro phosphatase assays with defined lipid substrates, cellular phosphoinositide measurement, apoptosis and autophagy assays

   PMID:22647598

   Open questions at the time

   • In vivo relevance of each pair not established
   • Subcellular site of catalysis not defined here
   • Regulation of which partner MTMR9 selects unknown
5. 2013 Medium

   Placed MTMR9 in an immune-regulatory context, showing it suppresses Th1 differentiation and AKT activation, implicating phosphoinositide control in T-cell fate.

   Evidence shRNA/siRNA knockdown in CD4 T cells, flow cytometry, AKT phosphorylation, in vivo bone marrow reconstitution

   PMID:23630283

   Open questions at the time

   • Which MTMR partner mediates the T-cell effect not identified
   • Direct link to a specific phosphoinositide species not shown
   • Mechanism connecting MTMR9 to AKT not resolved
6. 2019 Medium

   Defined a specific subcellular site and secretory function for MTMR9, showing it recruits active partners to the Golgi/intermediate compartment and regulates RAB1A and protein secretion.

   Evidence Immunofluorescence localization, siRNA knockdown and overexpression, co-localization with RAB1A and WHAMM, WNT3A secretion assay

   PMID:31704058

   Open questions at the time

   • Phosphoinositide species driving Golgi/secretory effects not pinpointed
   • Mechanism of RAB1A regulation unresolved
   • Direct interaction with RAB1A versus indirect effect not distinguished
7. 2022 Medium

   Distinguished MTMR9 from other MTMRs by showing it is not a critical determinant of neuronal autophagic clearance of TDP-43, refining the boundaries of its functional roles.

   Evidence shRNA knockdown with optical pulse labeling of TDP-43 turnover in iPSC-derived neurons

   PMID:35580604

   Open questions at the time

   • Negative result limited to TDP-43 and this neuronal context
   • Does not exclude autophagy roles in other cell types
8. 2024 Low

   Began to define the structural basis of MTMR9 oligomerization, showing its coiled-coil domain favors trimer formation, hinting at a higher-order assembly capacity distinct from partner MTMRs.

   Evidence Biophysical characterization of isolated coiled-coil domains and oligomerization assays

   PMID:39614773

   Open questions at the time

   • Single-lab biophysical study without cellular validation
   • Functional consequence of trimerization for phosphatase complexes unknown
   • Full-length protein assembly not characterized

• How MTMR9's choice of partner, its trimerization tendency, and its Golgi localization are coordinated to direct specific phosphoinositide outputs in distinct tissues remains unresolved.
• No structure of a full MTMR9-partner complex
• Determinants of partner selection in vivo unknown
• Direct mechanistic link between phosphoinositide changes and Th1/AKT and secretion phenotypes not established